Skip to main content

Cocrystal Pharma Inc (COCP) Stock

Cocrystal Pharma Inc Stock Details, Movements and Public Alerts

Stock Details

Cocrystal Pharma Inc (COCP), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $1.20. Over the past 52 weeks, it has ranged between $1.12 and $3.26. This places the current price at 36.8% of its 52-week high and 7.1% above its 52-week low. Recent trading volume was recorded at 164,140. The 14-day Relative Strength Index (RSI) stands at 41.45, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $1.56 by 23.08%. Similarly, it is below its 200-day moving average of $1.69 by 28.99%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.07, Signal Line: -0.07).

Market Cap

$17.08M

52-Week High

$3.26

-63.19% from high

52-Week Low

$1.12

+7.14% from low

Avg Daily Volume

950,750

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

PEG Ratio

0.00

Potentially undervalued

Price to Book

3.20

EV/EBITDA

0.66

EPS (TTM)

-$1.24

Price to Sales

92.45

Beta

2.28

More volatile than market

How is COCP valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is COCP's risk profile compared to the market?
With a beta of 2.28, Cocrystal Pharma Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 23% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 3.20 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

Return on Equity

-110.60%

Return on Assets

-52.90%

Revenue Growth (YoY)

26.90%

Earnings Growth (YoY)

0.00%

How profitable and efficient is COCP's business model?
Profitability metrics are not available for this stock.
What are COCP's recent growth trends?
Cocrystal Pharma Inc's revenue grew by 26.90% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Shares Outstanding

13.04M

Book Value/Share

$0.52

Asset Type

Common Stock

What is COCP's market capitalization and position?
Cocrystal Pharma Inc has a market capitalization of $17.08M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 13.04M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does COCP's price compare to its book value?
Cocrystal Pharma Inc's book value per share is $0.52, while the current stock price is $1.20, resulting in a price-to-book (P/B) ratio of 2.29. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$8.00

566.67% upside potential

Analyst Recommendations

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for COCP?
2 analysts cover COCP with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $8.00 implies 566.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on COCP?
Current analyst recommendations:1 Strong Buy, 1 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 24, 2025, 02:26 PM

Technical Indicators

RSI (14-day)

41.45

Neutral

50-Day Moving Average

$1.56

-23.08% below MA-50

200-Day Moving Average

$1.69

-28.99% below MA-200

MACD Line

-0.07

MACD Signal

-0.07

MACD Histogram

-0.01

Bearish

What does COCP's RSI value tell investors?
The RSI (Relative Strength Index) for COCP is currently 41.45, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret COCP's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.07 below the signal line at -0.07, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.56) is below the 200-day MA ($1.69), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Sep 25, 2025, 12:32 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for COCP and get notified when the price changes.

Stay Ahead of the Market with Cocrystal Pharma Inc Alerts

Set up price alerts for Cocrystal Pharma Inc and get notified instantly when the price hits your target. Never miss an important price movement again.